Unknown

Dataset Information

0

Prognosis of HIV Patients Receiving Antiretroviral Therapy According to CD4 Counts: A Long-term Follow-up study in Yunnan, China.


ABSTRACT: We aim to evaluate the overall survival and associated risk factors for HIV-infected Chinese patients on antiretroviral therapy (ART). 2517 patients receiving ART between 2006 and 2016 were prospectively enrolled in Yunnan province. Kaplan-Meier analyses and Cox proportional hazard regression analyses were performed. 216/2517 patients died during a median 17.5 (interquartile range [IQR] 6.8-33.2) months of follow-up. 82/216 occurred within 6 months of starting ART. Adjusted hazard ratios were10.69 (95%CI 2.38-48.02, p?=?0.002) for old age, 1.94 (95%CI 1.40-2.69, p?

SUBMITTER: Ren L 

PROVIDER: S-EPMC5575268 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognosis of HIV Patients Receiving Antiretroviral Therapy According to CD4 Counts: A Long-term Follow-up study in Yunnan, China.

Ren Li L   Li Juan J   Zhou Shiyi S   Xia Xueshan X   Xie Zhenrong Z   Liu Pan P   Xu Yu Y   Qian Yuan Y   Zhang Huifeng H   Ma Litang L   Pan Qiuwei Q   Wang Kunhua K  

Scientific reports 20170829 1


We aim to evaluate the overall survival and associated risk factors for HIV-infected Chinese patients on antiretroviral therapy (ART). 2517 patients receiving ART between 2006 and 2016 were prospectively enrolled in Yunnan province. Kaplan-Meier analyses and Cox proportional hazard regression analyses were performed. 216/2517 patients died during a median 17.5 (interquartile range [IQR] 6.8-33.2) months of follow-up. 82/216 occurred within 6 months of starting ART. Adjusted hazard ratios were10.  ...[more]

Similar Datasets

| S-EPMC5017266 | biostudies-literature
| S-EPMC5466653 | biostudies-literature
| S-EPMC6082173 | biostudies-literature
| S-EPMC3649850 | biostudies-literature
2005-01-18 | GSE1907 | GEO
| S-EPMC3159689 | biostudies-literature
| S-EPMC5340624 | biostudies-literature
| S-EPMC3921663 | biostudies-other
| PRJEB3227 | ENA
| PRJEB70954 | ENA